. Lecanemab and Vascular-Amyloid Deposition in Brains of People With Down Syndrome. JAMA Neurol. 2024 Oct 1;81(10):1066-1072. PubMed.

Recommends

Please login to recommend the paper.

Comments

No Available Comments

Make a Comment

To make a comment you must login or register.

This paper appears in the following:

Therapeutics

  1. Leqembi

Mutations

  1. Trisomy 21

News

  1. Questions, Questions for Donanemab, Lecanemab